Home Online Features MAXONA PHARMACEUTICALS EMERGES FROM STEALTH AS IT ACHIEVES MILESTONE IN DEVELOPMENT OF FIRST-TO-MARKET CANDIDATE MAX-001
MAXONA PHARMACEUTICALS EMERGES FROM STEALTH AS IT ACHIEVES MILESTONE IN DEVELOPMENT OF FIRST-TO-MARKET CANDIDATE MAX-001
Hand-out
Press Releases
Maxona Pharmaceuticals  
February 11, 2025

MAXONA PHARMACEUTICALS EMERGES FROM STEALTH AS IT ACHIEVES MILESTONE IN DEVELOPMENT OF FIRST-TO-MARKET CANDIDATE MAX-001

MAX-001 is a Non-Opioid, Non-NSAID Oral Therapy in Development for Acute and Chronic Pain

logo salamanca press

Salamanca Press

email salamanca press
Local & Social